Nonoperating Income (Expense) of CITIUS ONCOLOGY, INC. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CITIUS ONCOLOGY, INC. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • CITIUS ONCOLOGY, INC. Nonoperating Income (Expense) for the quarter ending 31 Dec 2025 was $17,553.
  • CITIUS ONCOLOGY, INC. annual Nonoperating Income (Expense) for 2025 was $181,659.
  • CITIUS ONCOLOGY, INC. annual Nonoperating Income (Expense) for 2023 was $3,432,374, a 561% increase from 2022.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $17,553 01 Oct 2025 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q2 2024 $3,251,554 $636,419 -$179,431 -22% 01 Apr 2024 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $3,430,985 $758,258 -$1,389 -0.18% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 $3,432,374 $1,277,479 01 Oct 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q3 2023 $579,398 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $815,850 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $759,647 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1

CITIUS ONCOLOGY, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $181,659 01 Oct 2024 30 Sep 2025 10-K 23 Dec 2025 2025 FY
2023 $3,432,374 +$2,913,448 +561% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
2022 $518,926 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.